By using this site, you agree to the Privacy Policy and Terms of Use.
Accept
AdkhabarAdkhabarAdkhabar
Notification Show More
Font ResizerAa
  • Home
  • Automobile
  • Entertainment
  • Esports
  • Food
  • Health
  • Life Style
  • News
  • Technology
  • Travel
Reading: Cellebrite to Report Fourth-Quarter and Fiscal Year 2025 Financial Results on February 11, 2026
Share
Font ResizerAa
AdkhabarAdkhabar
  • Home
  • Automobile
  • Entertainment
  • Esports
  • Food
  • Health
  • Life Style
  • News
  • Technology
  • Travel
Search
  • Home
  • Automobile
  • Entertainment
  • Esports
  • Food
  • Health
  • Life Style
  • News
  • Technology
  • Travel
Follow US
Adkhabar > Blog > News > Cellebrite to Report Fourth-Quarter and Fiscal Year 2025 Financial Results on February 11, 2026
Cellebrite to Report Fourth-Quarter and Fiscal Year 2025 Financial Results on February 11, 2026
News

Cellebrite to Report Fourth-Quarter and Fiscal Year 2025 Financial Results on February 11, 2026

Last updated: 21/01/2026 8:36 PM
Published: 21/01/2026
Share
SHARE

TYSONS CORNER, Va. and PETAH TIKVA, Israel, Jan. 21, 2026 /PRNewswire/ — Cellebrite (NASDAQ: CLBT), a global leader in premier Digital Investigative solutions for the public and private sectors, today announced it will report its fourth-quarter and fiscal year 2025 financial results before the U.S. markets open on Wednesday, February 11, 2026.

- Advertisement -

Later that same morning, Cellebrite will host a live conference call and webcast to review the Company’s financial results for the fourth quarter of 2025 and discuss its 2026 outlook. Relevant details include:

- Advertisement -

Date:

Wednesday, February 11, 2026

Time:

8:30 a.m. ET

Call-In Number:

203-518-9814 / 800-274-8461

Conference ID:  

CLBTQ425

Event URL:

https://investors.cellebrite.com/events/event-details/cellebrite-q4-2025-financial-results-conference-call-webcast

Live Webcast URL:

https://edge.media-server.com/mmc/p/v9sjjqnr

In conjunction with the conference call and webcast, historical financial tables and supplemental data will be available on the quarterly results section of Company’s investor relations website at https://investors.cellebrite.com/financial-information/quarterly-results.

- Advertisement -

About Cellebrite
Cellebrite’s (Nasdaq: CLBT) mission is to protect communities, nations and businesses as a global leader in digital investigative and intelligence solutions. More than 7,000 global law enforcement agencies, defense and intelligence organizations and enterprises trust Cellebrite’s AI-powered software portfolio to make forensically sound digital data more accessible and actionable. Cellebrite technology allows customers to accelerate more than 1.5 million legally sanctioned investigations annually, enhance sovereign security, elevate operational efficacy and efficiency and enable advanced mobile research and application security. Available via cloud, on-premises and hybrid deployments, Cellebrite’s technology enables its customers around the globe to advance their missions, elevate public safety and safeguard data privacy. To learn more, visit us at www.cellebrite.com, https://investors.cellebrite.com/investors and find us on social media @Cellebrite.

- Advertisement -

Investor Relations
Andrew Kramer
Vice President, Investor Relations
investors@cellebrite.com
+1 973.206.7760

- Advertisement -

Media
Victor Cooper
Sr. Director of Corporate Communications
Victor.cooper@cellebrite.com
+1 404.804.5910

- Advertisement -

Logo – https://mma.prnewswire.com/media/2855183/Cellebrite_Logo.jpg

- Advertisement -

View original content:https://www.prnewswire.co.uk/news-releases/cellebrite-to-report-fourth-quarter-and-fiscal-year-2025-financial-results-on-february-11-2026-302665739.html

- Advertisement -
TACC Positions India as a Global Hub for Advanced Energy Materials
Cipla Health welcomes FSSAI’s new labelling rules for ‘ORS’, reinforces Prolyte ORS as the #AsliORS
Junshi Biosciences Announces FDAs Approval of IND Application for Phase 2/3 Clinical Study of JS207 for the Neoadjuvant Treatment of NSCLC Patients
GOVY AirCab Makes Global Debut, GAC Unveils “Land-Air Matrix” at 2025 International Automotive & Supply Chain Expo (Hong Kong)
Xilio Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
TAGGED:$1120252026andcellebritefebruaryfinancialfiscalfourth quarternewsreportresultsyear
Share This Article
Facebook Email Print
- Advertisement -

Follow US

Find US on Social Medias
FacebookLike
XFollow
YoutubeSubscribe

Weekly Newsletter

Subscribe to our newsletter to get our newest articles instantly!
Popular News

Hyundai Motor Group Expands EV Energy Services with Vehicle to Grid and Vehicle to Home

TheNews Market
TheNews Market
28/11/2025
SERES Showcases Industry-Leading Innovations at Auto Guangzhou, Setting the Pace for the Future
Pictor Secures Funding to Accelerate U.S. Expansion through Partner-Informed Proteomics Solutions
Best GLP-1 Patch with Berberine (2026): Search Term Analysis as Consumers Explore Natural Transdermal Alternatives Vitamin Patch Club’s TrimPure Gold Referenced in Category Report
Domino India and Jumbo Blockchain Launch Made-in-India Traceability Solution to Tackle 2.62 Lakh Crore Counterfeit Crisis
- Advertisement -
- Advertisement -
- Advertisement -

Categories

  • Automobile
  • Entertainment
  • E-Sports
  • Food
  • Health
  • Technology
  • LifeStyle
  • Travel

About Us

Through our news networks, we raise millions of users' awareness. We are among the world's most reputable news networks.
Quick Link
Top Categories
  • Entertainment

Subscribe US

Subscribe to our newsletter to get our newest articles instantly!

AdkhabarAdkhabar
Copyright © 2021 - 2025 AdKhabar. All Rights Reserved. POWERED BY Life Care News.
Join Us!
Subscribe to our newsletter and never miss our latest news, podcasts etc..
Zero spam, Unsubscribe at any time.
Welcome Back!

Sign in to your account

Username or Email Address
Password

Lost your password?